3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-thiophene, 95.0%, 1g

3-(4-fluorophenyl)-1,4,8-triazaspiro[4.5]dec-3-en-2-one hydrochloride, 95.0%, 500mg

1-(3-BROMOPROPYL)-3-NITROBENZENE, 97%, 500mg

methyl (1S,4R)-4-aminocyclopent-2-ene-1-carboxylate hydrochloride, 98%, 1g

(2-Bromo-3-iodophenyl)methanamine, 97%, 100mg

Réservoir d'échantillon Visco, 300 ml, PTFE, FEP, 1 pièce

6-Bromo-benzothiazol-2-ylamine, 98.0%, 25g

(5aR,10bS)-2-(2,4,6-Triisopropylphenyl)-4,5a,6,10b-tetrahydroindeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate, 250mg

(R)-(2,3-dimethyl-3-((triethylsilyl)oxy)butyl)diphenylphosphine oxide, 97%, 1g

2,2-Dimethyl-1,3-benzodioxole>98.0%(GC)5g

5-Bromo-1,3-dichloro-2-methylbenzene, 95.0%, 10g

Colonne capillaire GC ROTI®Cap-1, 50 m, 0,32 mm, 0,50 µm, 1 pièce(s)

4-Amino-3,5,6-trichloropyridine-2-carboxylic acid, 97.0%, 100g